International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12887899
Original Research Article
Diagnostic Efficacy of Magnetic Resonance Imaging versus Ultrasound in the Evaluation of Scrotal Lesions: A Prospective Cross-sectional Study
Published
Nov. 5, 2024
Abstract

Objective: This study aims to evaluate the diagnostic efficacy of Magnetic Resonance Imaging (MRI) in assessing scrotal lesions, with a focus on differentiating between benign and malignant conditions. The limitations of ultrasound in some scrotal pathologies underscore the need for an advanced modality like MRI to improve diagnostic accuracy.Methods: A prospective cross-sectional study was conducted on 102 male patients presenting with symptoms of scrotal lesions. All participants underwent both ultrasound and MRI evaluations, with results compared against histopathological findings. Imaging sequences included T1-weighted, T2-weighted, and diffusion-weighted imaging (DWI). Statistical analyses included sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and ROC curves to assess MRI's diagnostic accuracy.Results: MRI showed higher diagnostic accuracy (96.1%) compared to ultrasound (91.2%) in identifying scrotal lesions. Specifically, MRI demonstrated sensitivity and specificity rates of 94.1% and 96.5%, respectively, while ultrasound showed 88.2% and 91.8%. ROC analysis further established MRI’s superior diagnostic performance in distinguishing between torsion, epididymo-orchitis, and malignancies.Conclusion: MRI is a valuable diagnostic tool for scrotal lesions, particularly in cases where ultrasound results are inconclusive. Its high sensitivity and specificity make MRI a recommended modality for comprehensive scrotal lesion evaluation

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
2004 Views
391 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved